Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus.
暂无分享，去创建一个
K. Latinis | F. Hiepe | W. Stohl | Mathew Thomas | A. Clarke | M. Scheinberg | C. Abud-Mendoza | T. Migone | W. Freimuth | W. Chatham | C. Aranow | Z. Zhong | L. Pineda | D. Hough | F. Wellborne | A. Clarke | Z. John | Zhong